MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Lateralization of fine motor actions in Tourette syndrome persisting through adulthood

    D. Martino, C. Delorme, E. Pelosin, A. Hartmann, Y. Worbe, L. Avanzino (Calgary, AB, Canada)

    Objective: To evaluate whether decreased lateralization of fine motor actions is an endophenotypic trait in adults with Tourette syndrome (TS), and whether it is related…
  • 2017 International Congress

    Rehabilitation program with or without a whey protein-based nutritional support enriched with essential aminoacids and vitamin D in patients with Parkinson’s disease or parkinsonism: study design of a randomized, controlled trial.

    m. barichella, E. Cereda, G. Pinelli, l. Iorio, V. Ferri, g. Frazzitta, E. Cassani, G. Riboldazzi, G. Pezzoli (Milano, Italy)

    Objective: Objective. To evaluate whether the use of a whey protein-based nutritional formula enriched with essential aminoacids – particularly leucine - and vitamin D have…
  • 2017 International Congress

    Noninvasive cerebellar stimulation for adults with cervical dystonia

    A. McCambridge (Sydney, Australia)

    Objective: To examine whether a 5 day treatment period of anodal transcranial direct current stimulation (a-tDCS) over the cerebellum would improve patients’ symptoms and alter…
  • 2017 International Congress

    History and Management of Status Dystonicus

    E. Nerrant, V. GONZALEZ, C. MILESI, T. Roujeau, E. Chan Seng, F. Cyprien, G. Cambonie, P. Coubes, L. CIF (Montpellier, France)

    Objective: To describe a consecutive series of 40 status dystonicus patients, identify major clinical characteristics and to document medical and surgical management. Background: Characteristics and evolution…
  • 2017 International Congress

    Brain volume changes in relation to intracortical inhibition and clinical benefit of pallidal stimulation in dystonia: a combined VBM and TMS study.

    R. Jech, A. Fečíková, V. Čejka, V. Čapek, D. Šťastná, F. Růžička, D. Urgošík, E. Růžička (Prague, Czech Republic)

    Objective: To explore the relationship between brain morphology, clinical effects of bilateral pallidal stimulation (GPi DBS) and intracortical inhibition of the motor cortex in patients…
  • 2017 International Congress

    Self-assessed psychological symptoms, fatigue and depersonalization in dystonia

    R. Newby, J. Alty, S. Jamieson, S. Smith, P. Kempster (Melbourne, Australia)

    Objective: To assess depressive, anxiety, fatigue and dissociative symptoms in patients with dystonia. Background: The basal ganglia, once considered exclusively concerned with motor control, are…
  • 2017 International Congress

    Focal dystonia as an early symptom of CACNA1A mutation: case report and literature review.

    Y. Gu, K. Kumar, C. Sue (Sydney, Australia)

    Objective: We describe two cases, a father-daughter pair, of CACNA1A mutation with task specific dystonia as an early feature. The father otherwise had a phenotype…
  • 2017 International Congress

    Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

    T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)

    Objective: To assess the frequency of extrapyramidal signs in patients with NS compared to patients with MS. Background: Specific inflammatory pathways and specifically Tumor necrosis…
  • 2017 International Congress

    Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study

    M. Amarandei (Bucharest, Romania)

    Objective: -the efficacy of the anti-CD20 antibody, Rituximab, in the treatment of patients with Stiff-person syndrome Background: SPS is a rare autoimmune progressive disorder of…
  • 2017 International Congress

    Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

    O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

    Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley